Presentation to highlight hypothermic oxygenated perfusion with VitaSmart in liver transplants, including pediatric patients and partial grafts
DULUTH, Ga., April 28, 2026 /PRNewswire/ — Bridge to Life Ltd, a global innovator in organ preservation solutions and perfusion technology, announced today the presentation of 12 accepted abstracts (five oral, including one plenary session presentation, and seven poster presentations, including one late-breaking) at the 2026 International Liver Transplantation Society (ILTS) Congress. The conference is scheduled to take place in Geneva, Switzerland from May 6 to 9, 2026.
All times are expressed in Central European Summer Time (CEST), UTC+2.
Oral Presentation Summaries
Abstract Title: “Donor Serum FMN Reflects Mitochondrial Injury and Predicts Outcomes After Liver Transplantation: A Metabolic Donor Signature of Graft Quality”
Session Title: Simultaneous Oral Session 4: Selection Criteria, Patient Selection, Organ Allocation
Date/Time: Thursday, May 7, 2026 from 13:45 to 15:00
Presenter: Fatma Selin Yildirim, Cleveland Clinic
Abstract Title: “Prolonged HOPE Preserves Mitochondrial Function and Enables Logistical Flexibility in Liver Transplantation”
Session Title: Simultaneous Oral Session 5: Fundamental Science, Translational Research, and Tolerance Induction 1
Date/Time: Thursday, May 7, 2026 from 15:15 to 16:30
Presenter: Omer Faruk Karakaya, Cleveland Clinic
Abstract Title: “Perfusate Microbiology Before and After Hypothermic Oxygenated Perfusion: A Missing Piece in Graft Evaluation”
Session Title: Simultaneous Oral Session 7: Immunosuppression and Infection
Date/Time: Friday, May 8, 2026, 10:45 – 12:00
Presenter: Marco Pascale, Policlinico Universitario Agostino Gemelli
Abstract Title: “A Donor Risk Factor-Inclusive Machine Learning Equation for Predicting Cholangiocarcinoma Recurrence After Liver Transplantation”
Session Title: Simultaneous Oral Session 13: Comorbidities and Outcomes of Liver Transplantation II
Date/Time: Friday, May 8, 2026, 14:45 – 16:00
Presenter: Laura Batista De Oliveira, Cleveland Clinic
Abstract Title: “Prolonged Hypothermic Oxygenated Perfusion in Pediatric Partial Liver Grafts: A Bicentric Experience in the UK”
Session Title: Plenary Session 2
Date/Time: Saturday, May 9, 2026, 8:00 – 9:15
Presenter: Alba Bueno, Birmingham Children’s Hospital
Poster Presentations
Late-Breaking Abstract:
Poster Title: “Sequential Normothermic Regional Perfusion and Hypothermic Oxygenated Machine Perfusion in Liver Grafts from Donors After Circulatory Death Can Protect Against Ischemic Cholangiopathy”
Presenter: Sergio Cortese, Gregorio Maranon University Hospital
*Please note: The rest of the poster presentations and speakers are listed in the original content.
Bridge to Life Symposium
Bridge to Life will also sponsor a lunchtime symposium, “The Future of Machine Perfusion: Combining Strategies, Optimizing Care, and Expanding Possibilities,” on May 7, 12:45 – 13:45 CEST (UTC+2) at Palexpo 1 Conference Center, Room K. Several speakers will be featured.
About Bridge to Life Ltd
Bridge to Life Ltd is a leading provider of organ preservation solutions, offering top products such as Belzer UW, EasiSlush, and the hypothermic oxygenated perfusion system VitaSmart. Focusing on product quality, innovation, and accessibility, the company serves major transplantation centers and organ procurement organizations worldwide, with whom it collaborates closely.
Logo – [Link to Logo Image]
/2026/04/28/69f117f89a6a6249609878.jpg "In front of the American Congress, Charles III calls on the United States to remain faithful to their western allies")
